Probing the N-terminal beta-sheet conversion in the crystal structure of the full-length human prio… | |
Heteromer
| 117-225 | |
Assess |
Probing the N-terminal beta-sheet conversion in the crystal structure of the human prion protein bo… | |
Heteromer
| 118-224 | |
Assess |
Human prion protein (PrP) fragment 119-231 (G127V M129 variant) complexed to ICSM 18 (anti-Prp ther… | |
Heteromer
| 125-225 | 1×SO4; |
Assess |
Human prion protein (PrP) fragment 119-231 (G127V V129 variant) complexed to ICSM 18 (anti-Prp ther… | |
Heteromer
| 125-223 | 1×SO4; |
Assess |
Structure of ICSM 18 (anti-Prp therapeutic antibody) Fab fragment complexed with human Prp fragment… | |
Heteromer
| 125-223 | 1×SO4; |
Assess |
Structure of POM1 FAB fragment complexed with human PrPc Fragment 120-230 | |
Heteromer
| 126-222 | 1×NA; |
Assess |
Fragment of human prion protein | |
Heteromer
| 177-216 | 3×FE; 4×CIT; |
Assess |
Fragment of human prion protein | |
Heteromer
| 177-216 | |
Assess |
Cryo-EM structure of human PrP23-144 amyloid fibrils | | homo-20-mer | 108-141 | |
Assess |
GYMLGS segment 127-132 from human prion with M129 | | homo-12-mer | 127-132 | |
Assess |
GYVLGS segment 127-132 from human prion with V129 | | homo-12-mer | 127-132 | 12×ACY; |
Assess |
Structure of Type I Prion filaments from Gerstmann-Straussler-Scheinker disease | | homo-10-mer | 80-141 | |
Assess |
Structure of Type II Prion filaments from Gerstmann-Straussler-Scheinker disease | | homo-10-mer | 80-141 | |
Assess |
Cryo-EM structure of amyloid fibril formed by full-length human prion protein | | homo-10-mer | 170-229 | |
Assess |
Human prion protein fibril, M129 variant | | homo-10-mer | 106-145 | |
Assess |
IIHFGS segment 138-143 from human prion | | homo-10-mer | 138-143 | 10×MPD; |
Assess |
GAVVGG segment 119-124 from human prion | | homo-8-mer | 119-124 | |
Assess |
AGAAAA segment 113-118 from human prion | | homo-8-mer | 113-118 | 8×MLI; |
Assess |
Cryo-EM structure of amyloid fibril formed by familial prion disease-related mutation E196K | | homo-6-mer | 175-217 | |
Assess |
Crystal structure of the human prion protein reveals a mechanism for oligomerization | | homo-2-mer | 119-226 | 4×CD; 2×CL; |
Assess |
Human prion protein variant V129 domain swapped dimer | | homo-2-mer | 120-225 | 2×CD; 2×CL; |
Assess |
Human prion protein variant D178N with M129 | | homo-2-mer | 126-228 | 2×CD; |
Assess |
Human prion protein variant F198S with V129 | | homo-2-mer | 125-227 | 2×CD; |
Assess |
Human prion protein variant V129 domain swapped dimer | | homo-2-mer | 125-227 | |
Assess |
Human prion protein variant F198S with M129 | | homo-2-mer | 125-226 | 2×CD; |
Assess |
Human prion protein variant D178N with V129 | | homo-2-mer | 126-223 | 2×CD; 2×CL; |
Assess |
Human prion protein with E219K protective polymorphism | | monomer | 90-231 | |
Assess |
human prion protein mutant HuPrP(90-231, M129, V210I) | | monomer | 90-231 | |
Assess |
Three dimensional structure of HuPrP(90-231 M129 Q212P) | | monomer | 90-231 | |
Assess |
Solution-state NMR structure of the human prion protein | | monomer | 90-231 | |
Assess |
Solution-state NMR structure of prion protein mutant V210I at neutral pH | | monomer | 90-231 | |
Assess |
structure for wildtype Human prion protein (M129) | | monomer | 91-231 | |
Assess |
Solution structure of the pathogenic mutant G131V of Human prion protein (91-231) | | monomer | 91-231 | |
Assess |
structure for the protective mutant G127V of Human prion protein | | monomer | 91-231 | |
Assess |
PrP226* - Solution-state NMR structure of truncated human prion protein | | monomer | 90-226 | |
Assess |
HUMAN PRION PROTEIN 121-230 M166C/E221C | | monomer | 119-230 | |
Assess |
Solution NMR structure of the V209M variant of the human prion protein (residues 90-231) | | monomer | 120-231 | |
Assess |
HUMAN PRION PROTEIN MUTANT E200K FRAGMENT 90-231 | | monomer | 125-231 | |
Assess |
NMR Studies of a Pathogenic Mutant (D178N) of the Human Prion Protein | | monomer | 125-231 | |
Assess |
HUMAN PRION PROTEIN (MUTANT E200K) FRAGMENT 90-231 | | monomer | 125-231 | |
Assess |
Human prion protein fragment 90-230 | | monomer | 125-228 | |
Assess |
Human prion protein variant R220K | | monomer | 125-228 | |
Assess |
HUMAN PRION PROTEIN AT PH 7.0 | | monomer | 125-228 | |
Assess |
Human prion protein variant R220K | | monomer | 125-228 | |
Assess |
Human prion protein variant S170N | | monomer | 125-228 | |
Assess |
HUMAN PRION PROTEIN AT PH 7.0 | | monomer | 125-228 | |
Assess |
Human prion protein variant S170N | | monomer | 125-228 | |
Assess |
Human prion protein fragment 121-230 | | monomer | 125-228 | |
Assess |
Human prion protein variant M166V | | monomer | 125-228 | |
Assess |
Human prion protein fragment 90-230 | | monomer | 125-228 | |
Assess |
Human prion protein fragment 121-230 | | monomer | 125-228 | |
Assess |
Human prion protein | | monomer | 125-228 | |
Assess |
Human prion protein | | monomer | 125-228 | |
Assess |
Human prion protein variant M166V | | monomer | 125-228 | |
Assess |
Human prion protein variant V129 | | monomer | 125-227 | |
Assess |
Crystal Structure of Human Prion Protein 90-231 | | monomer | 127-224 | 3×CD; 1×CL; |
Assess |
Structure of the CHR of the Prion protein in DPC Micelles | | monomer | 110-136 | |
Assess |
Human prion protein 61-84 | | monomer | 61-84 | |
Assess |
hPrP-173-195 solution structure | | monomer | 173-195 | |
Assess |
hPrP-173-195-D178N solution structure | | monomer | 173-195 | |
Assess |
hPrP180-195 structure | | monomer | 180-195 | |
Assess |
Segment from the S170N mutant of the human prion protein 168-176 EYNNQNNFV | | monomer | 168-176 | |
Assess |
Segment from the Y169F mutant of the human prion protein 168-176 EFSNQNNFV | | monomer | 168-176 | |
Assess |
Segment from the human prion protein 168-176 EYSNQNNFV | | monomer | 168-176 | |
Assess |
Human prion protein 61-68 | | monomer | 77-84 | |
Assess |
Segment from the human prion protein 169-175 YSNQNNF | | monomer | 169-175 | |
Assess |
Segment from Y169G mutant of the human prion protein 169-175 GSNQNNF | | monomer | 169-175 | 1×ACT; 1×ZN; |
Assess |
Prion peptide | | monomer | 127-132 | |
Assess |
Prion peptide | | monomer | 127-132 | |
Assess |